USA flag logo/image

An Official Website of the United States Government

CHOICE POINTS--BREAST CANCER TREATMENT CD ROM

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
45649
Program Year/Program:
1999 / SBIR
Agency Tracking Number:
1R43CA080565-01
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
HEALTHMARK MULTIMEDIA, LLC
HEALTHMARK MULTIMEDIA, LLC 1828 L ST NW, STE 250 WASHINGTON, DC 20036 0263
View profile »
Woman-Owned: Yes
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1999
Title: CHOICE POINTS--BREAST CANCER TREATMENT CD ROM
Agency: HHS
Contract: N/A
Award Amount: $99,954.00
 

Abstract:

Not Available The proposed DDARPASBIR program would demonstrate the synthesis of retinal protein-based optoelectronic arrays using self-assembly techniques. The proposed method utilizes NanoSonic's patented and exclusively licensed molecular-level electrostatic self-assembly (ESA) approach to biomimetically grow multilayered active electronic devices. The selection of specific molecules and their processing into individual device monolayers by alternate ionic attraction and bonding allows the formation of adjacent photoactive, electrode and packaging layers. Prior NanoSonic research has demonstrated our ability to form ultrauniform many-layer films of proteins, noble metal and metal oxide nanoclusters, cage structured molecules and other materials by this process. The photoactive and electrode elements may be patterned in two-dimensions at the nanolevel, through control of the local isoelectric point during ESA processing. During the Phase I program, NanoSonic would demonstrate the incorporation of retinal and related photoactive molecules into uniform multilayered thin films by the ESA process, investigate the self-assemby of nanostructured electrodes leading to the formation of two-dimensional optoelectronic device arrays, study ways in which spectral sensitivity may be modified, and fabricate devices and evaluate their spectral and temporal responses. During Phase II, NanoSonic would work with several identified larger companies to transition the ESA processing of biologically-inspired optoelectronic devices to commercial manufacturing.

Principal Investigator:

Susan G. Brink

Business Contact:


2022650033
EM: AMCFARREN@HEALTHMARKMULTIMEDIA.CO
Small Business Information at Submission:

HEALTHMARK MULTIMEDIA, LLC
1201 CONNECTICUT AVE NW, #250 WASHINGTON, DC 20036

EIN/Tax ID: 521666065
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No